Miragen Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Miragen Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Miragen Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Miragen Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.8M | 84k | 21.75 |
| 2023-09-30 | $1.7M | 110k | 15.33 |
| 2023-03-31 | $5.8M | 228k | 25.44 |
| 2022-12-31 | $1.7M | 57k | 29.21 |
| 2022-09-30 | $1.1M | 53k | 20.51 |
| 2021-12-31 | $294k | 15k | 19.75 |